Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7938)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2016 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shen GS, Zhao JD, Zhao JH, Ma XF, Du F, Kan J, Ji FX, Ma F, Zheng FC, Wang ZY, Xu BH. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China. World J Gastroenterol 2016; 22(23): 5406-5414 [PMID: 27340357 DOI: 10.3748/wjg.v22.i23.5406] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i23/5406.htm |
| Number | Citing Articles |
| 1 |
Christoph Röcken. Molecular classification of gastric cancer. Expert Review of Molecular Diagnostics 2017; 17(3): 293 doi: 10.1080/14737159.2017.1286985
|
| 2 |
Weiling Li, Xiaoling Zhang, Yunyi Du, Ying Zhang, Jing Lu, Wenqing Hu, Jun Zhao. HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives. Biomarker Research 2022; 10(1) doi: 10.1186/s40364-022-00416-x
|
| 3 |
Akihiro Sekimoto, Hideo Miyake, Hidemasa Nagai, Yuichiro Yoshioka, Norihiro Yuasa. Predictors of 1‐year mortality after gastrectomy for gastric cancer. World Journal of Surgery 2024; 48(1): 138 doi: 10.1002/wjs.12005
|
| 4 |
Hyeongbin Kim, SangHyuk Seo, KwangHee Kim, Yo-Han Park, MinSung An, HyungJoo Baik, ChangSoo Choi, SangHoon Oh. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1652-2
|
| 5 |
Zimin Liu, Mingpeng Shi, Xiaoxiao Li, Shanai Song, Ning Liu, Haiwei Du, Junyi Ye, Haiyan Li, Zhou Zhang, Lu Zhang. HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma. Journal of Cancer Research and Clinical Oncology 2021; 147(5): 1315 doi: 10.1007/s00432-021-03522-9
|
| 6 |
Xinxin Shao, Shenghua Zhan, Qiuying Quan, Yu Shen, Siji Chen, Xueguang Zhang, Rui Li, Mi Liu, Lei Cao. Clinical significance of B7-H3 and HER2 co-expression and therapeutic value of combination treatment in gastric cancer. International Immunopharmacology 2022; 110: 108988 doi: 10.1016/j.intimp.2022.108988
|
| 7 |
Fausto Petrelli, Michele Ghidini, Sandro Barni, Francesca Steccanella, Giovanni Sgroi, Rodolfo Passalacqua, Gianluca Tomasello. Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies. Annals of Surgical Oncology 2017; 24(9): 2655 doi: 10.1245/s10434-017-5832-4
|
| 8 |
Hong-Bo Wang, Xiao-Feng Liao, Jian Zhang. Clinicopathological factors associated with HER2-positive gastric cancer. Medicine 2017; 96(44): e8437 doi: 10.1097/MD.0000000000008437
|
| 9 |
Honglei Chen, Kaitao Yuan, Xinyou Wang, Huashe Wang, Qiuning Wu, Xiaobin Wu, Junsheng Peng. Overexpression of RECQL4 is associated with poor prognosis in patients with gastric cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.9318
|
| 10 |
Luigi Spagnoli, Federica Petrelli, Bruno Perotti, Marco Arganini, Maria Raffaella Ambrosio. Gastrointestinal Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 4: 101 doi: 10.1007/16833_2023_184
|
| 11 |
Fang Li, Guiqing Meng, Bibo Tan, Zihao Chen, Qiang Ji, Xiaoxiao Wang, Chang Liu, Shuyao Niu, Yong Li, Yueping Liu. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis. Pathology - Research and Practice 2021; 217: 153280 doi: 10.1016/j.prp.2020.153280
|
| 12 |
xinxin shao, Shenghua Zhan, Qiuying Quan, Yu Shen, Siji Chen, Xueguang Zhang, Rui Li, Mi Liu, Lei Cao. Clinical Significance of B7-H3 and HER2 Co-Expression and Therapeutic Value of Combination Treatment in Gastric Cancer. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4095072
|
| 13 |
Xiaoqian Jing, Zhiping Luo, Jiayan Wu, Feng Ye, Jianfang Li, Zijia Song, Yaqi Zhang, Minmin Shi, Huaibo Sun, Yi Fang, Yimei Jiang, Xiaopin Ji. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD‐L1 expression. Cancer Medicine 2023; 12(24): 21905 doi: 10.1002/cam4.6765
|
| 14 |
Matthew S. Strand, Albert Craig Lockhart, Ryan C. Fields. Genetics of Gastric Cancer. Surgical Clinics of North America 2017; 97(2): 345 doi: 10.1016/j.suc.2016.11.009
|
| 15 |
Qiyin Zhou, Xi Lan, Ni Li, Daozu Yuan, Jiliang Zhang. Analysis of Prognostic Factors and Design of Prognosis Model for Patients with Stage IV Gastric Cancer Following First-Line Palliative Chemotherapy. Cancer Management and Research 2020; : 10461 doi: 10.2147/CMAR.S263320
|
| 16 |
Li-Fei Sun, Kun Yang, Yi-Gao Wang, Yu-Xin Liu, Pei-Xian Hou, Zheng-Hao Lu, Xiao-Long Chen, Wei-Han Zhang, Zong-Guang Zhou, Xian-Ming Mo, Jian-Kun Hu. The Role of HER2 in Self-Renewal, Invasion, and Tumorigenicity of Gastric Cancer Stem Cells. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01608
|